We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Second FDA Import Ban Increases Wockhardt’s Regulatory Hurdles
Second FDA Import Ban Increases Wockhardt’s Regulatory Hurdles
The FDA Nov. 27 hit Wockhardt with a second “import alert,” banning drug products from its Chikalthana plant in western India — the latest in a spate of regulatory actions taken against the struggling drugmaker.